chartexchange
EDTUTC-4 New York
Sign up
FeedbackDocs

LCTX
Lineage Cell Therapeutics, Inc.
stockNYSEAMERICAN

At CloseOct 2, 2026 3:59:55 PM EDT
0.93USD+2.687%(+0.02)1,249,311
Pre-marketOct 2, 2026 9:29:30 AM EDT
0.95USD+5.065%(+0.05)
After-hoursOct 2, 2026 4:53:30 PM EDT
0.9201USD-0.905%(-0.0084)
Loading…
Loading…
Market Cap
234.94M
Sector
Healthcare
Industry
Biotechnology
HQ
Carlsbad, CA, USA
Employees
70
Previous Close
$0.90
Beta
1.37
52-Week High
$2.09 2025-11-03
52-Week Low
$0.88 2026-10-01
SMA 50
$1.06
SMA 200
$1.40
Avg. Vol 10D
1.75M
Avg. Vol 30D
1.32M
Avg. Vol 90D
1.36M
Relative Vol
0.95
Shares Out
252.91M
Float
236.53M
Free Float %
93.53%
Short Interest
29,468,651
Short Interest %
12.46%
Days to Cover
26.64
On/Off Exchange
48%/52%
Short Vol %
68.71%
Short Vol % (off-exch)
55.03%
Borrow Fee
0.6900%
Borrow Avail.
10,000,000
FTDs
187
FTDs 30d avg
2,558
FTDs 30d high
15,053
Next Earnings
Nov 5, 2026 (31d)
LCTX Profile

biotime, inc. is a clinical-stage biotechnology company focused on developing and commercializing novel therapies developed from what we believe to be the world's premier collection of pluripotent cell assets. the foundation of our core therapeutic technology platform is pluripotent cells that are capable of becoming any of the cell types in the human body. pluripotent cells have potential application in many areas of medicine with large unmet patient needs, including various age-related degenerative diseases and degenerative conditions for which there presently are no cures. unlike pharmaceuticals that require a molecular target, therapeutic strategies based on the use of pluripotent cells are generally aimed at regenerating or replacing affected cells and tissues, and therefore may have broader applicability than pharmaceutical products.

LCTX Performance
PeriodPriceDateChangeBeta
1W0.972026-09-28-4.33%3.380
1M1.082026-09-04-13.99%1.020
3M1.332026-07-06-30.15%1.344
6M1.542026-04-06-39.68%1.067
1Y1.692025-10-03-45.03%1.370
2Y0.912024-10-04+2.08%—
5Y2.452021-10-04-62.08%1.079
LCTX Stock Summary

Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX) stock price today is $0.93, and today's volume is 1,249,311. LCTX is up 2.737% today. The 30 day average volume is 1.32M. LCTX market cap is $234.94M with 252.91M shares outstanding.